Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets - Institut Pasteur Accéder directement au contenu
Article Dans Une Revue Journal of Controlled Release Année : 2016

Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets

Uwe Maskos

Résumé

Detection of intracerebral targets with imaging probes is challenging due to the non-permissive nature of blood-brain barrier (BBB). The present work describes two novel single-domain antibodies (VHHs or nanobodies) that specifically recognize extracellular amyloid deposits and intracellular tau neurofibrillary tangles, the two core lesions of Alzheimer’s disease (AD). Following intravenous administration in transgenic mouse models of AD, in vivo real-time two-photon microscopy showed gradual extravasation of the VHHs across the BBB, diffusion in the parenchyma and labeling of amyloid deposits and neurofibrillary tangles. Our results demonstrate that VHHs can be used as specific BBB-permeable probes for both extracellular and intracellular brain targets and suggest new avenues for therapeutic and diagnostic applications in neurology.
Fichier principal
Vignette du fichier
JCR-Final2.pdf (14.36 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

pasteur-01375692 , version 1 (03-10-2016)

Licence

Paternité

Identifiants

Citer

Tengfei Li, Matthias Vandesquille, Fani Koukouli, Clémence Dudeffant, Ihsen Youssef, et al.. Camelid single-domain antibodies: A versatile tool for in vivo imaging of extracellular and intracellular brain targets. Journal of Controlled Release, 2016, 243, pp.1 - 10. ⟨10.1016/j.jconrel.2016.09.019⟩. ⟨pasteur-01375692⟩
2158 Consultations
1585 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More